Self-reported age-related eye diseases and visual impairment in the United States: Results of the 2002 National Health Interview Survey

Self-reported age-related eye diseases and visual impairment in the United States: Results of the 2002 National Health Interview Survey
复制标题

DOI:
10.2105/ajph.2006.098202
复制
发表时间:
2008-03-01
影响因子:
12.7
通讯作者:
Janiszewski, Rosemary
Janiszewski, Rosemary
中科院分区:
医学2区
文献类型:
--
作者:
Ryskulova, Asel;Turczyn, Kathleen;Janiszewski, Rosemary

文献摘要

被引文献

相似文献

目标。我们试图建立关于视力障碍、失明和特定眼部疾病(白内障、糖尿病视网膜病变、青光眼和黄斑变性)患病率的国家数据,并在社会人口学亚组中描述这些疾病的特征。方法。从 31044 名成年人中收集了有关自我报告的视力障碍和诊断的眼部疾病的信息。我们使用 SUDAAN.Results 通过逻辑回归计算了加权患病率估计值和优势比。在 18 岁及以上非收容美国成年人中,视力障碍患病率估计为 9.3%(1,910 万美国人),其中失明率为 0.3%(70 万)。诊断疾病的终生患病率如下:白内障,8.6%(1700万人);青光眼,2.0%(400 万);黄斑变性,1.1%(200万);和糖尿病视网膜病变,0.7%(130 万)。诊断为糖尿病的人中糖尿病视网膜病变的患病率为9.9%。结论。我们提供有关美国自我报告的视力障碍和特定眼部疾病的最新可用国家数据。这项研究的结果为未来与视力障碍相关的公共卫生举措提供了基线。
Objectives. We sought to establish national data on the prevalence of visual impairment, blindness, and selected eye conditions (cataract, diabetic retinopathy, glaucoma, and macular degeneration) and to characterize these conditions within sociodemographic subgroups.Methods. Information on self-reported visual impairment and diagnosed eye diseases was collected from 31044 adults. We calculated weighted prevalence estimates and odds ratios with logistic regression using SUDAAN.Results. Among noninstitutionalized US adults 18 years and older, the estimated prevalence for visual impairment was 9.3% (19.1 million Americans), including 0.3% (0.7 million) with blindness. Lifetime prevalence of diagnosed diseases was as follows: cataract, 8.6% (17 million); glaucoma, 2.0% (4 million); macular degeneration, 1.1% (2 million); and diabetic retinopathy, 0.7% (1.3 million). The prevalence of diabetic retinopathy among persons with diagnosed diabetes was 9.9%.Conclusions. We present the most recently available national data on self-reported visual impairment and selected eye diseases in the United States. The results of this study provide a baseline for future public health initiatives relating to visual impairment.